Head of the administration's pharmaceutical group Hung Kuo-teng said the products in question have been assessed in line with international standards, and five APIs in popular heart medications, namely Valsartan, Losartan, Irbesartan, Olmesartan
and Candesartan contained harmful components and have been taken under further investigation.
medoxomil (OLME), CAS = 144689-63-4,1Himidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester, is a prodrug that is subjected to enzymatic hydrolysis, and its active product, olmesartan
, is an angiotensin II receptor blocker (ARB) used in treatment and prophylaxis of hypertension.
M2 PHARMA-July 18, 2017-FDA approves Alembic Pharmaceuticals' ANDA for Olmesartan
Medoxomil and Amlodipine tablets
Glenmark Pharmaceuticals has received final approval from the US health regulator for Amlodipine and Olmesartan
Medoxomil tablets, used in the treatment of hypertension.
M2 EQUITYBITES-May 26, 2017-Glenmark Pharma gains US FDA approval for its blood pressure generic Olmesartan
Abacavir sulfate and lamivudine tablets in 600 mg and 300 mg doses is a generic bioequivalent of VIV Healthcare's Epzicom tablets, used to treat HIV-1 infection, while olmesartan
medoxomil and hydrochlorothiazide tablets, 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg, have been judged therapeutically equivalent to Daiichi Sankyo Ltd.'s Benicar HCT, which is used to treat hypertension.
SHRs were randomly assigned into three treatment groups (n = 5 for each): SHR + QL group, fed with QL powder suspension (0.5 g/kg x d); SHR + olmesartan
group, fed with olmesartan
(2.5 mg/kg x d); SHR + saline group: given equal volume of saline alone.
2 -- Ajanta Pharma Limited, announces today US FDA* approval and launch of Amlodipine + Olmesartan
Medoxomil Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc.
This study aimed to assess the effectiveness of olmesartan
in the prevention of new-onset AF and AF burden in atrioventricular block (AVB) patients with dual-chamber (DDD) pacemaker implantation.
In a multivariate analysis, physicians who received a single meal related to the promoted drug were 1.8 times more likely to prescribe rosuvastatin than other statins, 1.7 times more likely to prescribe nebivolol than other beta-blockers, 1.5 times more likely to prescribe olmesartan
than other ACE inhibitors or angiotensin II receptor blockers, and more than twice as likely to prescribe desvenlafaxine than other SSRIs and serotonin norepinephrine reuptake inhibitors (odds ratio, 2.18).
More than a thousand legal actions have been lodged in the US over the drug Olmesartan
- also known as Olmetec.